CARL GOLDFISCHER
CIK 1110780 · last filed 2025-06-20
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$63.55M
Companies
7
Total Filings
80
Lifetime Open-Market Net
-$25.74M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | 29,019 | $28.69 | $832.6K | $0 | 7 | 2025-06-20 |
| IMRA | Director | 703,380 | $17.02 | $11.97M | $0 | 2 | 2022-06-03 |
| Epizyme, Inc. (EPZM) Delisted | Director | 3,403,005 | $1.47 | $5.00M | -$25.72M | 18 | 2022-05-19 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | 4,294 | $32.48 | $139.5K | -$584.7K | 11 | 2019-02-08 |
| ReShape Weightloss Inc. (ETRM) Delisted | Director | 0 | — | — | $9.81M | 21 | 2017-05-31 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Director | 314,227 | — | — | $378.0K | 10 | 2011-06-10 |
| MAPP | Director | 1,859,987 | $27.73 | $51.58M | -$9.63M | 6 | 2010-05-21 |
Recent Filings · Page 2 of 8
80 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-28 | Damora Therapeutics, Inc. (GLTO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-13 | Epizyme, Inc. (EPZM) Delisted | Buy (P) | +5,000 | $60.4K | EDGAR |
| 2020-11-04 | Damora Therapeutics, Inc. (GLTO) Delisted | Mixed | +1,049,055 | $0 | EDGAR |
| 2020-06-02 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-07 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-08 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$42.3K | EDGAR |
| 2019-01-31 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-31 | Epizyme, Inc. (EPZM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-23 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Mixed | — | -$117.5K | EDGAR |
| 2018-01-26 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.